glp-1 kidney outcomes news today Updated evidence on cardiovascular and renal effects of receptor agonists and combination therapy with SGLT2 inhibitors and finerenone: a narrative review and perspectives | Cardiovascular Diabetology GLP-1 Receptor Agonist Use in

In a pancreatic tumor model, the combination of amifostine and stereotactic body radiotherapy nearly tripled survival time in mice, which if translated to humans could be an enormous breakthrough, adding years of survival to patients

Incretin effect is essential for the postprandial glucose controls, as it is responsible for 5070% of insulin secretion after oral glucose intake in non-diabetic subjects 1

We start with a thorough, personalized approach so you can feel confident, supported, and in control every step of the way

Perioperative management of long-acting glucagon-like peptide-1 (GLP-1) receptor agonists: concerns for delayed gastric emptying and pulmonary aspiration

Novo Nordisk launched Ozempic in December 2017 when the FDA approved Ozempic for Type 2 diabetes

In many lawsuits, patients were hospitalized and required feeding tubes or surgical intervention